Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.

PubWeight™: 2.19‹?› | Rank: Top 2%

🔗 View Article (PMID 15663986)

Published in J Steroid Biochem Mol Biol on December 21, 2004

Authors

Gerald R Cunha1, Will Ricke, Axel Thomson, Paul C Marker, Gail Risbridger, Simon W Hayward, Y Z Wang, Annemarie A Donjacour, Takeshi Kurita

Author Affiliations

1: Department of Anatomy, University of California, Box 0452, 513 Parnassus Avenue, San Francisco, CA 94143-0452, USA. grcunha@itsa.ucsf.edu

Articles citing this

Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol (2005) 3.19

Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci U S A (2007) 1.93

Targeting the tumor microenvironment. Front Biosci (2007) 1.72

Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol (2010) 1.57

Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues. Prostate (2014) 1.50

Breast and prostate cancer: more similar than different. Nat Rev Cancer (2010) 1.48

Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res (2011) 1.47

Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation (2011) 1.42

Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol (2008) 1.41

CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Mol Endocrinol (2010) 1.35

Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol (2009) 1.25

Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries. BMC Genomics (2009) 1.24

Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Prostate (2013) 1.15

Stromal progesterone receptors mediate induction of Indian Hedgehog (IHH) in uterine epithelium and its downstream targets in uterine stroma. Endocrinology (2009) 1.14

CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol (2010) 1.11

Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol (2011) 1.09

Sox9 is required for prostate development and prostate cancer initiation. Oncotarget (2012) 1.09

The role of androgen receptor mutations in prostate cancer progression. Curr Genomics (2009) 1.07

A high throughput in situ hybridization method to characterize mRNA expression patterns in the fetal mouse lower urogenital tract. J Vis Exp (2011) 1.07

Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med (2012) 1.06

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov (2013) 1.03

Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice. Endocrinology (2008) 1.01

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed (2011) 0.99

Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate. Dev Biol (2008) 0.98

Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Mol Endocrinol (2011) 0.97

The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. Am J Pathol (2009) 0.97

Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system. J Steroid Biochem Mol Biol (2011) 0.94

Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate. Asian J Androl (2009) 0.93

An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells. J Cell Sci (2008) 0.93

Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen. PLoS One (2012) 0.92

Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol (2007) 0.92

Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One (2011) 0.92

Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocr Rev (2008) 0.92

Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells. PLoS One (2013) 0.91

Identification of EpCAM as a molecular target of prostate cancer stroma. Am J Pathol (2009) 0.91

AR function in promoting metastatic prostate cancer. Cancer Metastasis Rev (2014) 0.91

Endodermal origin of bladder trigone inferred from mesenchymal-epithelial interaction. J Urol (2010) 0.90

Age-related histopathological lesions in the Mongolian gerbil ventral prostate as a good model for studies of spontaneous hormone-related disorders. Int J Exp Pathol (2008) 0.89

Androgen receptor drives cellular senescence. PLoS One (2012) 0.89

Disruption of prostate epithelial differentiation pathways and prostate cancer development. Front Oncol (2013) 0.89

Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor. PLoS One (2011) 0.88

Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system. Spermatogenesis (2013) 0.86

Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer. Am J Pathol (2014) 0.85

Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene (2014) 0.85

Etiopathogenesis of benign prostatic hypeprlasia. Indian J Urol (2009) 0.84

Intersection of AHR and Wnt signaling in development, health, and disease. Int J Mol Sci (2014) 0.82

Expression and functional role of sprouty-2 in breast morphogenesis. PLoS One (2013) 0.81

Deletion of androgen receptor in the smooth muscle of the seminal vesicles impairs secretory function and alters its responsiveness to exogenous testosterone and estradiol. Endocrinology (2010) 0.81

Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages. Int J Exp Pathol (2009) 0.80

Evaluating baculovirus as a vector for human prostate cancer gene therapy. PLoS One (2013) 0.80

Differential Inductive Signaling of CD90 Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells. Cancer Microenviron (2011) 0.80

Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice. PLoS One (2013) 0.80

Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World J Clin Oncol (2013) 0.79

Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions. Differentiation (2008) 0.79

Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies. Anticancer Agents Med Chem (2010) 0.79

Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. Prostate (2015) 0.79

Exposure to ethinylestradiol during prenatal development and postnatal supplementation with testosterone causes morphophysiological alterations in the prostate of male and female adult gerbils. Int J Exp Pathol (2011) 0.79

Comparison of Picrosirius Red Staining With Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples. J Histochem Cytochem (2016) 0.79

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Oncotarget (2015) 0.78

The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones. Asian J Androl (2011) 0.78

Evidence of histidine and aspartic acid phosphorylation in human prostate cancer cells. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.78

Soiling the seed: microenvironment and epithelial mesenchymal plasticity. Cancer Microenviron (2012) 0.78

Dose-related estrogen effects on gene expression in fetal mouse prostate mesenchymal cells. PLoS One (2012) 0.78

The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis. Asian J Androl (2012) 0.77

Prostate cancer stroma: an important factor in cancer growth and progression. Bosn J Basic Med Sci (2015) 0.77

Overexpression of FGF9 in prostate epithelial cells augments reactive stroma formation and promotes prostate cancer progression. Int J Biol Sci (2015) 0.77

A novel androgen signalling pathway uses dihydrotestosterone, but not testosterone, to activate the EGF receptor signalling cascade in prostate stromal cells. Br J Pharmacol (2013) 0.77

LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.76

Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics. Transl Androl Urol (2015) 0.76

Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development. Stem Cells Dev (2016) 0.76

5-alpha-reductase and the development of the human prostate. Indian J Urol (2008) 0.76

Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development. J Steroid Biochem Mol Biol (2014) 0.76

A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. Cancers (Basel) (2017) 0.75

Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression. Hum Pathol (2016) 0.75

Androgen signaling disruption during fetal and postnatal development affects androgen receptor and connexin 43 expression and distribution in adult boar prostate. Biomed Res Int (2013) 0.75

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells. J Mol Endocrinol (2013) 0.75

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression. Oncotarget (2016) 0.75

Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity. J Biol Chem (2012) 0.75

Prenatal exposure to ethinylestradiol alters the morphologic patterns and increases the predisposition for prostatic lesions in male and female gerbils during ageing. Int J Exp Pathol (2016) 0.75

Articles by these authors

Hormonal, cellular, and molecular control of prostatic development. Dev Biol (2003) 2.67

Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol (2004) 2.55

NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol (2008) 2.44

Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer (2003) 2.43

Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene (2005) 2.35

Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development (2005) 2.31

Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res (2002) 2.29

Role of stroma in carcinogenesis of the prostate. Differentiation (2002) 2.26

Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol (2009) 2.20

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res (2007) 2.02

ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development (2012) 1.97

Regulation of the cell cycle machinery by oncogenic ras. Oncogene (1996) 1.92

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev (2013) 1.91

Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med (1996) 1.69

Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res (2004) 1.66

Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest (2012) 1.63

A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63

Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res (2011) 1.62

Mouse urogenital development: a practical approach. Differentiation (2003) 1.59

Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate (2005) 1.57

Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res (2005) 1.56

A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Eur Urol (2013) 1.51

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate (2005) 1.49

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network. Prostate (2014) 1.49

Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis (1989) 1.48

Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ (2001) 1.43

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene (2010) 1.43

Differential effects of carbon dioxide and pH on central chemoreceptors in the rat in vitro. J Physiol (1985) 1.39

Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36

Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res (2006) 1.36

Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology (2010) 1.36

Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res (2008) 1.36

Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models. Gynecol Oncol (2005) 1.33

Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer (2006) 1.32

Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol (2001) 1.29

The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer (2008) 1.28

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Cancer Res (2004) 1.24

Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem (2008) 1.23

New insights on the morphology of adult mouse penis. Biol Reprod (2011) 1.22

Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res (2009) 1.22

The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Res (2009) 1.21

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy. Gynecol Oncol (2008) 1.20

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest (2005) 1.19

Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem (2000) 1.19

Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res (2011) 1.18

Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol (2007) 1.17

The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy (2008) 1.17

Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer. Oncogene (2007) 1.17

Methodologies in assaying prostate cancer stem cells. Methods Mol Biol (2009) 1.16

A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One (2008) 1.14

Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate (2007) 1.14

Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proc Natl Acad Sci U S A (2010) 1.13

Cohort study among workers exposed to benzene in China: II. Exposure assessment. Am J Ind Med (1994) 1.12

Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract (2002) 1.12

Growth factors and epithelial-stromal interactions in prostate cancer development. Int Rev Cytol (2000) 1.12

Branching morphogenesis in the prostate gland and seminal vesicles. Differentiation (2006) 1.10

Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res (2012) 1.10

High-level of xylanase production by the thermophilic Paecilomyces themophila J18 on wheat straw in solid-state fermentation. Bioresour Technol (2005) 1.10

Directed differentiation of embryonic stem cells into bladder tissue. Dev Biol (2007) 1.10

Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells (2010) 1.09

Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration. Differentiation (2005) 1.09

Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol (2001) 1.08

Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. Cancer Res (2007) 1.08

Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice. Endocrinology (2012) 1.07

Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci U S A (2002) 1.07

Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis. J Biol Chem (2002) 1.06

An epidemiologic study of early biologic effects of benzene in Chinese workers. Environ Health Perspect (1996) 1.05

Morphology of the external genitalia of the adult male and female mice as an endpoint of sex differentiation. Mol Cell Endocrinol (2011) 1.05

Abnormal urethra formation in mouse models of split-hand/split-foot malformation type 1 and type 4. Eur J Hum Genet (2007) 1.04

Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation (2008) 1.04

Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene (2009) 1.04

Informing men about prostate cancer screening: a randomized controlled trial of patient education materials. J Gen Intern Med (2008) 1.03

Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis (2012) 1.03

Role of stem cells in human uterine leiomyoma growth. PLoS One (2012) 1.02

Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol (2008) 1.02

Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci U S A (2001) 1.02

Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction. Differentiation (2007) 1.01

Accuracy of administrative and trauma registry databases. J Trauma (2001) 1.01

Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev (2001) 1.00

Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett (2004) 1.00

Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate. Dev Biol (2008) 0.98

Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A (2013) 0.98

The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol (2012) 0.98

5-HT activates neural reflexes regulating secretion in the guinea-pig colon. Neurogastroenterol Motil (1997) 0.98

PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation (2011) 0.97

Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development. Endocrinology (2012) 0.96

Targeting the tumor stroma as a novel therapeutic approach for prostate cancer. Adv Pharmacol (2012) 0.96

An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol Cell Biol (2006) 0.96

Cohort study among workers exposed to benzene in China: I. General methods and resources. Am J Ind Med (1994) 0.95

Role of systemic and local IGF-I in the effects of estrogen on growth and epithelial proliferation of mouse uterus. Endocrinology (2002) 0.95

TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One (2010) 0.95

Mortality among benzene-exposed workers in China. Environ Health Perspect (1996) 0.95

Analysis of the effect of estrogen/androgen perturbation on penile development in transgenic and diethylstilbestrol-treated mice. Anat Rec (Hoboken) (2013) 0.95

Solitary fibrous tumor of the sinonasal cavity: CT and MR imaging findings. AJNR Am J Neuroradiol (2013) 0.95

Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens. Differentiation (2012) 0.95

A deficit in strabismic amblyopia for global shape detection. Vision Res (1999) 0.94

Are judgements of circularity local or global? Vision Res (1999) 0.93